Atlas Trials

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Clinical trial NCT03647215 · COMPLETED

Trial details

NCT number
NCT03647215
Sponsor
Incyte Biosciences UK
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Phase Chronic Myelogenous LeukemiaAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaPhiladelphia Chromosome-positive Acute Lymphoblastic Leukemia
Start date
2017-12-18
Primary completion
2021-03-31
Enrollment
427

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.